Joslin & Harvard Medical School

Our affiliation with Harvard Medical School gives Joslin researchers opportunities to collaborate with other investigators with complementary interests and expertise through the Harvard Stem Cell Institute.

Joslin investigators participate in various Institute activities:

• Gordon C. Weir, M.D., heads the diabetes program.
• T. Keith Blackwell, M.D., Ph.D., Head of Joslin's Section on Developmental and Stem Cell Biology, co-directs an internal stem cell seminar program.
• Susan Bonner-Weir, Senior Investigator in Joslin's Section on Islet Transplantation and Cell Biology, heads up the membership committee.

Additionally, Amy J. Wagers, Ph.D., Principal Investigator from Joslin's Section on Developmental and Stem Cell Biology, and Rohit Kulkarni, M.D., Ph.D., Principal Investigator from Joslin's Cellular and Molecular Physiology Section, were among 12 scientists to receive the first seed grants from the Harvard Stem Cell Institute.

Lastly, most Joslin researchers and clinicians have academic appointments at Harvard Medical School and several are involved in Ph.D. training at the medical school.

For those of you who are researchers, go to joslinresearch.org site.